Quest Diagnostics To Acquire Laboratory Services Business Of Oxford Immunotec

(RTTNews) - Quest Diagnostics (DGX) Tuesday announced a definitive agreement to acquire the U.S. laboratory services business of Oxford Immunotec Global Plc (OXFD). The transaction is expected to be completed in the fourth quarter of 2018. The financial aspects of the deal were not revealed.

The acquisition, once completed, will include the T-SPOT.TB tuberculosis and the Accutix tick-borne disease testing services provided by Oxford Immunotec's laboratories. As part of the deal, Oxford Immunotec will sell T-SPOT.TB test kits and related accessories to Quest Diagnostics under the terms of a long-term supply agreement.

Quest Diagnostics said it intends to continue to offer QuantiFERON TB blood testing services to provide physicians choice in blood-based TB testing.